ASTRO says "blanket no-testing policy" is wrong.
With BrightMatter, 20-30 inoperable cases may become treatable
Jessica also previews their upcoming International Symposium in October in Washington D.C.
The cost of over-prescribed antibiotics goes far beyond funds
Observations and key takeaways from Rob Cascella, the CEO of Philips' Imaging Business Group
Shedding light on the pleasure of a sad song
As testing volumes decrease, will manufacturers be affected?
Proton beam and CT make the list.
Appointed CEO of InSightec as company secures $22 million round D investment
The Jacobus Report
With reimbursement around the corner, the sector may explode
Horace talks about the upcoming Annual Georgia Biomedical Instrumentation Society Conference
Measures brain iron levels
We're witnessing a time of unprecedented leaps forward when it comes to diagnosing and treating various cancers
Several design and technology advancements
With emerging research identifying increased challenges for screening dense breasts, manufacturers are making adjustments.
Philips continues to improve its imaging portfolio.
Will it replace SPECT?
Seven Winners Selected for Programs That Improve Patient Care and Safety
Neiman dies at 71 after long illness.
Acquisition gives Dutch nuclear medicine company better access to U.S. markets.